People under the age of 23 should have access to sexchange hormones
On 7 November 2026, Debatrix hosted a live, moderated debate on "teenagers and young adults have the right to access sexchange hormones" in the General category. 2 participants joined the panel. The session ran for 13 minutes across 1 exchanges.
AI-Generated Debate Summary
The debate centered on whether young people should have access to sex‑changing hormones. Karla argued that providing these hormones to minors is irresponsible because the changes are largely irreversible and can lead to lasting psychological harm, citing testimonies of individuals who regret transitioning at a young age. She also emphasized the need for greater maturity, suggesting that decisions should be postponed until ages 21‑23. While acknowledging that lack of access can cause depression, she maintained that the risks of premature medical intervention outweigh the benefits. The discussion highlighted the tension between protecting vulnerable youth from potential regret and ensuring trans individuals can access gender‑affirming care without undue barriers.
Arguments For
- Lack of access to gender‑affirming hormones can cause depression and emotional distress for trans youth who feel unable to become the person they identify as.
Arguments Against
- Hormone treatments are largely irreversible and can lead to permanent physical changes that some individuals later regret.
- Early medical transition is associated with lasting psychological impacts, including regret and mental health challenges later in life.
- Young people may lack the necessary maturity and long‑term perspective to make such permanent decisions responsibly.